IRIS Accounts Production v24.2.0.383 13464407 Board of Directors 1.8.23 31.7.24 31.7.24 false true false false false true false Ordinary B 0.0100 Ordinary A 0.0100 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh134644072023-07-31134644072024-07-31134644072023-08-012024-07-31134644072022-07-31134644072022-08-012023-07-31134644072023-07-3113464407ns15:EnglandWales2023-08-012024-07-3113464407ns14:PoundSterling2023-08-012024-07-3113464407ns10:Director12023-08-012024-07-3113464407ns10:PrivateLimitedCompanyLtd2023-08-012024-07-3113464407ns10:SmallEntities2023-08-012024-07-3113464407ns10:AuditExemptWithAccountantsReport2023-08-012024-07-3113464407ns10:SmallCompaniesRegimeForDirectorsReport2023-08-012024-07-3113464407ns10:SmallCompaniesRegimeForAccounts2023-08-012024-07-3113464407ns10:FullAccounts2023-08-012024-07-311346440712023-08-012024-07-3113464407ns10:OrdinaryShareClass12023-08-012024-07-3113464407ns10:OrdinaryShareClass22023-08-012024-07-3113464407ns10:Director32023-08-012024-07-3113464407ns10:Director42023-08-012024-07-3113464407ns10:Director52023-08-012024-07-3113464407ns10:RegisteredOffice2023-08-012024-07-3113464407ns5:CurrentFinancialInstruments2024-07-3113464407ns5:CurrentFinancialInstruments2023-07-3113464407ns5:Non-currentFinancialInstruments2024-07-3113464407ns5:Non-currentFinancialInstruments2023-07-3113464407ns5:ShareCapital2024-07-3113464407ns5:ShareCapital2023-07-3113464407ns5:RetainedEarningsAccumulatedLosses2024-07-3113464407ns5:RetainedEarningsAccumulatedLosses2023-07-3113464407ns5:IntangibleAssetsOtherThanGoodwill2023-08-012024-07-3113464407ns5:PatentsTrademarksLicencesConcessionsSimilar2023-08-012024-07-3113464407ns5:PatentsTrademarksLicencesConcessionsSimilar2023-07-3113464407ns5:PatentsTrademarksLicencesConcessionsSimilar2024-07-3113464407ns5:PatentsTrademarksLicencesConcessionsSimilar2023-07-3113464407ns5:CurrentFinancialInstrumentsns5:WithinOneYear2024-07-3113464407ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-07-3113464407ns10:OrdinaryShareClass12024-07-3113464407ns10:OrdinaryShareClass22024-07-31
REGISTERED NUMBER: 13464407 (England and Wales)















Unaudited Financial Statements

for the Year Ended 31 July 2024

for

Pasco Medical Limited

Pasco Medical Limited (Registered number: 13464407)






Contents of the Financial Statements
for the Year Ended 31 July 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4

Chartered Accountants' Report 7

Pasco Medical Limited

Company Information
for the Year Ended 31 July 2024







DIRECTORS: Dr K M Obszanski
Z Wang
X Wu
Ms S Zhang





REGISTERED OFFICE: Hanover Court
5 Queen Street
Lichfield
Staffordshire
WS13 6QD





REGISTERED NUMBER: 13464407 (England and Wales)





ACCOUNTANTS: Tomkinson Teal (Lichfield) LLP
Hanover Court
5 Queen Street
Lichfield
Staffordshire
WS13 6QD

Pasco Medical Limited (Registered number: 13464407)

Balance Sheet
31 July 2024

2024 2023
Notes £    £   
FIXED ASSETS
Intangible assets 4 3,986 730

CURRENT ASSETS
Debtors 5 39,799 49,755
Cash at bank 22,950 5,378
62,749 55,133
CREDITORS
Amounts falling due within one year 6 (11,200 ) (3,261 )
NET CURRENT ASSETS 51,549 51,872
TOTAL ASSETS LESS CURRENT
LIABILITIES

55,535

52,602

CREDITORS
Amounts falling due after more than one
year

7

(439,989

)

(359,990

)
NET LIABILITIES (384,454 ) (307,388 )

CAPITAL AND RESERVES
Called up share capital 8 20 20
Retained earnings (384,474 ) (307,408 )
SHAREHOLDERS' FUNDS (384,454 ) (307,388 )

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 July 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 July 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Pasco Medical Limited (Registered number: 13464407)

Balance Sheet - continued
31 July 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Profit and Loss Account has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 12 September 2024 and were signed on its behalf by:





Ms S Zhang - Director


Pasco Medical Limited (Registered number: 13464407)

Notes to the Financial Statements
for the Year Ended 31 July 2024

1. STATUTORY INFORMATION

Pasco Medical Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Patents and licences are being amortised evenly over their estimated useful life of nil years.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Profit and Loss Account, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Going concern
The directors/investors are committed to supporting the company and therefore these accounts have been prepared under the going concern basis.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2023 - 1 ) .

Pasco Medical Limited (Registered number: 13464407)

Notes to the Financial Statements - continued
for the Year Ended 31 July 2024

4. INTANGIBLE FIXED ASSETS
Patents
and
licences
£   
COST
At 1 August 2023 730
Additions 3,256
At 31 July 2024 3,986
NET BOOK VALUE
At 31 July 2024 3,986
At 31 July 2023 730

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade debtors 35,231 45,408
Amounts owed by group undertakings 10 10
Tax 1,968 -
VAT 1,577 2,169
Prepayments 1,013 2,168
39,799 49,755

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade creditors 10,000 1,177
Social security and other taxes - 884
Accrued expenses 1,200 1,200
11,200 3,261

7. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
2024 2023
£    £   
Directors' loan accounts 439,989 359,990

8. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2024 2023
value: £    £   
19,220 Ordinary B 0.1p 10 10
10,000 Ordinary A 0.1p 10 10
20 20

Pasco Medical Limited (Registered number: 13464407)

Notes to the Financial Statements - continued
for the Year Ended 31 July 2024

9. RELATED PARTY DISCLOSURES

The directors have made loans to the company and it is intended these loans will not be repaid until after the third anniversary of the company, the amounts are included in other creditors in note 7 to the accounts.

Chartered Accountants' Report to the Board of Directors
on the Unaudited Financial Statements of
Pasco Medical Limited

The following reproduces the text of the report prepared for the directors in respect of the company's annual unaudited financial statements. In accordance with the Companies Act 2006, the company is only required to file a Balance Sheet. Readers are cautioned that the Income Statement and certain other primary statements and the Report of the Directors are not required to be filed with the Registrar of Companies.

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Pasco Medical Limited for the year ended 31 July 2024 which comprise the Profit and Loss Account, Balance Sheet, Statement of Changes in Equity and the related notes from the company's accounting records and from information and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed within the ICAEW's regulations and guidance at http://www.icaew.com/en/membership/regulations-standards-and-guidance.

This report is made solely to the Board of Directors of Pasco Medical Limited, as a body, in accordance with our terms of engagement. Our work has been undertaken solely to prepare for your approval the financial statements of Pasco Medical Limited and state those matters that we have agreed to state to the Board of Directors of Pasco Medical Limited, as a body, in this report in accordance with ICAEW Technical Release 07/16AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Pasco Medical Limited and its Board of Directors, as a body, for our work or for this report.

It is your duty to ensure that Pasco Medical Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and loss of Pasco Medical Limited. You consider that Pasco Medical Limited is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the financial statements of Pasco Medical Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.






Tomkinson Teal (Lichfield) LLP
Hanover Court
5 Queen Street
Lichfield
Staffordshire
WS13 6QD


12 September 2024